Cambria Investment Management »

Cytomx Therapeutics shares owned by Cambria Investment Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Cambria Investment Management from 13F filings

Historical chart of Cambria Investment Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Cambria Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Cambria Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $134k 31k 4.26

More positions owned by Cambria Investment Management

Cambria Etf Tr Cambria Fgn Shr (FYLD)
Cambria Etf Tr Global Value Etf (GVAL)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Cambria Etf Tr Value Momentum (VAMO)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Cambria Etf Tr Gbl Real Est Etf (BLDG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr Series Trust Bloomberg Enhncd (CERY)
Exxon Mobil Corporation (XOM)
Cambria Etf Tr Glb Moment Etf (GMOM)
Graniteshares Gold Tr Shs Ben Int (BAR)
Tidal Trust Ii Cambria Chesapea (MFUT)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Invesco Db Multi-sector Comm Precious Metal (DBP)

View all positions for Cambria Investment Management

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Point72 Asset Management
State Street Corporation
Balyasny Asset Management
ADAR1 Capital Management
Baker Bros. Advisors
Financial Engines Advisors L.L.C
Kynam Capital Management
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics